• ML216: Unlocking BLM Helicase Inhibition for MSI Cancer Rese

  2026-07-17

  Explore the advanced science behind ML216, a BLM helicase inhibitor, as a precision tool for investigating DNA repair and synthetic lethality in mismatch repair-deficient cancers. This article offers an in-depth analysis of ML216’s mechanism, unique applications, and practical assay insights grounded in recent landmark research.

• Septin4 Promotes Cardiomyocyte Injury via HIF-1α Degradation

  2026-07-17

  This study reveals that Septin4 intensifies hypoxia-induced cardiomyocyte apoptosis by promoting HIF-1α ubiquitination and degradation through the VHL pathway. These findings illuminate a previously unrecognized mechanism underlying myocardial ischemia injury and suggest new targets for modulating hypoxia responses in cardiovascular disease.

• GI 254023X: Precision ADAM10 Inhibitor for Vascular & Cell M

  2026-07-16

  GI 254023X unlocks new experimental workflows for dissecting ADAM10-mediated signaling and vascular barrier integrity. Its unmatched selectivity and robust in vitro/vivo validation set a new benchmark for apoptosis and endothelial injury studies.

• Pioglitazone as a PPARγ Agonist: Advanced Insights for Immun

  2026-07-16

  Explore the multifaceted role of pioglitazone as a PPARγ agonist in immunometabolic research. This article offers an in-depth analysis of mechanism, protocol optimization, and translational impact, bridging metabolic and inflammatory models for next-generation assay design.

• 2',7'-Dichlorofluorescein Diacetate: Optimizing Intracellula

  2026-07-15

  2',7'-Dichlorofluorescein diacetate empowers precise, quantitative intracellular ROS measurement in live-cell assays, transforming cancer biology and redox drug discovery workflows. This guide details advanced protocol enhancements, troubleshooting strategies, and key innovations that set APExBIO’s probe apart for translational research.

• Mono-ADP-Ribosylation Marks PARP7 and AHR for Degradation

  2026-07-15

  This study reveals that endogenous mono-ADP-ribosylation of PARP7 and AHR serves as a degradation signal, uncovered by blocking the ubiquitin pathway. The findings clarify the interplay between ADP-ribosylation and proteasomal degradation, providing new mechanistic insight into AHR signaling regulation.

• Deep Learning Uncovers Cardiotoxicity in iPSC-CMs Screening

  2026-07-14

  Grafton et al. present a scalable deep learning approach for early detection of drug-induced cardiotoxicity using high-content imaging of iPSC-derived cardiomyocytes. This framework enables efficient identification of cardiotoxic compounds and informs safer drug development pipelines.

• Oxaliplatin in Translational Oncology: Workflows and Optimiz

  2026-07-14

  Oxaliplatin, a platinum-based chemotherapeutic agent, is pivotal for modeling DNA damage-induced apoptosis and chemoresistance in cancer research. This guide unpacks experimental workflows, evidence-driven protocol refinements, and troubleshooting levers to maximize Oxaliplatin’s impact in both in vitro and in vivo studies.

• Phosbind Biotin LC: Practical Guide for Phosphorylated Prote

  2026-07-13

  Phosbind Biotin LC offers a robust alternative to phospho-specific antibodies for detecting phosphorylated proteins in Western Blot workflows, using ionic binding to phosphate groups regardless of sequence. It is not suitable for aqueous-only protocols or for long-term storage as a working solution; optimal use relies on freshly prepared solutions in compatible organic solvents.

• Bafilomycin C1: Precision V-ATPase Inhibitor for Autophagy A

  2026-07-13

  Bafilomycin C1 empowers researchers to dissect autophagy, apoptosis, and lysosomal function with high specificity, facilitating robust phenotypic screening in disease-relevant cell models. Its application in high-content imaging and iPSC-based workflows is redefining early drug safety assessment and mechanistic discovery.

• Ruthenium Red as a Ca2+ Transport Inhibitor: Workflows & Inn

  2026-07-12

  Ruthenium Red, a high-affinity Ca2+ transport inhibitor from APExBIO, empowers researchers to precisely dissect calcium signaling and mechanotransduction in cutting-edge autophagy and inflammation models. This article delivers workflow enhancements, troubleshooting strategies, and actionable insights rooted in the latest cytoskeleton-dependent autophagy research.

• Deep Learning Reveals Cardiotoxicity Using iPSC-derived Card

  2026-07-10

  Grafton et al. present a scalable deep learning-based phenotypic screening method to detect drug-induced cardiotoxicity in human iPSC-derived cardiomyocytes. Their approach improves early-stage identification of cardiotoxic compounds, offering a promising tool to enhance drug safety in discovery pipelines.

• Cisapride (R 51619): De-risking Cardiotoxicity with iPSC-CMs

  2026-07-09

  This article provides translational researchers with actionable guidance on leveraging Cisapride (R 51619) as a dual-mechanism tool in predictive cardiotoxicity assays. By connecting molecular mechanism, iPSC-derived cardiomyocyte models, and deep learning analytics, it offers strategies to optimize early-stage drug safety workflows and highlights how APExBIO's high-purity Cisapride sets a new benchmark for robust cardiac electrophysiology research.

• AZD6482: PI3Kβ Inhibitor Workflows for Translational Researc

  2026-07-09

  AZD6482 sets a new benchmark in targeted PI3Kβ inhibition, empowering researchers to dissect key signaling pathways with precision. This guide gives hands-on protocol insights, troubleshooting strategies, and practical connections to recent discoveries in disease modeling, making it indispensable for advanced translational studies.

• Probenecid: Strategic Inhibitor for Translational Breakthrou

  2026-07-08

  This thought-leadership article unpacks the mechanistic and strategic impact of Probenecid (4-(dipropylsulfamoyl)benzoic acid) as a dual-action inhibitor in multidrug resistance and neuroprotection research. Drawing on recent evidence and best practices, it guides translational researchers in leveraging Probenecid for more reproducible, insightful, and clinically relevant assays.

16042 records 1/1070 page Next 12345 下5页 Last page